Morphine Mouthwash in Oral Mucositis: A Mini Review

Crossmark: check for updates

Authors

  • Kalpajit Dutta
  • Rakesh Garg

DOI:

https://doi.org/10.17140/PMHCOJ-2-115

Keywords:

Morphine, Mouthwash, Adverse effects, Mucositis, Cancer

Abstract

Oral mucositis is a frequent adverse effect of chemotherapy and radiation therapy in cancer patients. The mucositis impacts overall quality of life (QoL) by producing pain with variable intensity leading to difficulty in oral intake, lack of sleep, etc. A multimodal therapy is advocated for management of oral mucositis in cancer patients and includes certain preventive and therapeutic interventions aiming at symptom control. The systemic analgesics are frequently used but may be associated various side effects associated with analgesics including opioid. The use of oral submucosal route for opioids has been advocated in view of existence of peripheral opioid receptors for its analgesic property. We review the literature for use of morphine mouthwash for management of painful oral mucosisits.

References

Quinn B, Potting CM, Stone R, et al. Guidelines for the as-sessment of oral mucositis in adult chemotherapy, radiotherapy and haematopoietic stem cell transplant patients. Eur J Cancer. 2008; 44: 61-72. doi: 10.1016/j.ejca.2007.09.014

Epstein J. Current developments in treating chemotherapy re-lated oral mucositis. Clin Adv Hematol Oncol. 2003; 1: 712-713.

Scully C, Epstein J, Sonis S. Oral mucositis: A challenging complication of radiotherapy, chemotherapy, and radiochemo-therapy. Part 2: Diagnosis and management of mucositis. Head Neck. 2004; 26: 77-84. doi: 10.1002/hed.10318

Sonis ST, Elting LS, Keefe D, et al. Mucositis Study Section of the Multinational Association for Supportive Care in Cancer; International Society for Oral Oncology: Perspectives on cancer therapy induced mucosal injury: Pathogenesis, measurement, epidemiology, and consequences for patients. Cancer. 2004; 100(Suppl 9): 1995-2025. doi: 10.1002/cncr.20162

Urba S. Concurrent chemoradiation for head and neck can-cer. In: Perry MC, ed. American Society of Clinical Oncology Educational Book. Alexandria, VA, USA: American Society of Clinical Oncology; 2000: 215-218.

Forastiere A. Concurrent cisplatinum and radiation for ad-vanced head and neck cancer. Int J Radiat Oncol Biol Phys.1995; 31: 679-680.

Marcial V, Pajak TF, Mohiuddin M, et al. Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck. Long-term results of the Radiation Therapy Oncology Group study 81-17. Cancer. 1990; 66: 1861-1868. doi: 10.1002/1097-0142 (19901101)66:9<1861::AID-CNCR2820660902>3.0.CO;2-I

Denham J, Abbott R. Concurrent cisplatin, infusional fluo-rouracil and conventionally fractionated radiation therapy in head and neck cancer: Dose limiting mucosal toxicity. J Clin Palliat Med Hosp Care Open J Oncol. 1991; 9: 458-463. Web site. http://jco.ascopubs.org/con-tent/9/3/458.short. Accessed August 24, 2016.

Epstein JB, Schubert MM. Managing pain in mucosi-tis. Semin Oncol Nurs. 2004; 20(1): 30-37. doi: 10.1053/j. soncn.2003.10.006

Epstein JB, Silverman S Jr, Paggiarino DA, et al. Benzyda-mine HCl for prophylaxis of radiation-induced oral mucositis: Results from a multicenter, randomized, double-blind, place-bo-controlled clinical trial. Cancer. 2001; 92(4): 875-885. doi: 10.1002/1097-0142(20010815)92:4<875::AID-CNCR1396> 3.0.CO;2-1

Rosenthal DI. Consequences of mucositis-induced treatment breaks and dose reductions on head and neck cancer treatment outcomes. J Support Oncol. 2007; 5: 23-31. Web site. http:// europepmc.org/abstract/med/18046995. Accessed August 24, 2016.

Loprinzi CL, Dose AM. Studies on the prevention of 5-fluo-rouracil- induced oral mucositis. Natl Cancer Inst Monogr. 1990; 9: 93-94. Web site. http://europepmc.org/abstract/med/2342597. Accessed August 24, 2016.

Miaskowski C. Management of mucositis during therapy. Natl Cancer Inst Monogr. 1990; 9: 95-98.

National Institutes of Health consensus development confer-ence on oral complications of cancer therapies: Diagnosis, pre-vention and treatment. Natl Cancer Inst Monogr. 1990; 9: 1-184.

Stein C. Peripheral mechanism of opioid analgesia. Anesth Analg. 1993; 76: 182-191.

Fields HL, Emson PC, Leigh BK, Gilbert RFT, Iversen LL. Multiple opiate receptor sites on primary afferent fibres. Nature. 1980; 284: 351-353. doi: 10.1038/284351a0

LaMotte C, Pert CB, Snyder SH. Opiate receptor binding in primate spinal cord: Distribution and changes after dorsal root section. Brain Res. 1976; 112: 407-412. doi: 10.1016/0006- 8993(76)90296-1

Stein C, Hassan AHS, Przewlocki R, Gramsch C, Peter K, Herz A. Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation. Proc Natl Acad Sci. 1990; 87: 5935-5939. doi: 10.1073/pnas.87.15.5935

Hassan AHS, Ableitner A, Stein C, Herz A. Inflammation of the rat paw enhances axonal transport of opioid receptors in the sciatic nerve and increases their density in the inflamed tissue. Neuroscience. 1993; 55: 185-195.

Schafer M, Imai Y, Uhl GR, Stein C. Inflammation enhances peripheral opioid analgesia, but not opioid receptor transcription in dorsal root ganglia. Eur J Pharmacol. 1995; 279: 165-169. doi: 10.1016/0014-2999(95)00150-J

Likar R, Koppert W, Blatnig H, et al. Efficacy of peripheral morphine analgesia in inflamed, non-inflamed and perineural tissue of dental surgery patients. J Pain Sympton Manage. 2001; 21: 330-337. doi: 10.1016/S0885-3924(01)00251-2

Rubenstein EB, Peterson DE, Schubert M, et al. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer. 2004; 100: 2026-2046. doi: 10.1002/cncr.20163

LeBon B, Zeppetella G, Higginson IJ. Effectiveness of topical administration of opioids in palliative care: A system-atic review. J Pain Symptom Manage. 2009; 37: 913-917. doi: 10.1016/j.jpainsymman.2008.06.007

Charbaji N, Schäfer-Korting M, Küchler S. Morphine stimu-lates cell migration of oral epithelial cells by delta-opioid recep-tor activation. PLoS One. 2012; 7: e4261-e4266. doi: 10.1371/ journal.pone.0042616

Beckett AH, Hossie RD. Buccal absorption of drugs. Hand-book Exp Pharmacol. 1971; 28: 24-46. doi: 10.1007/978-3-642- 65052-9_3

Schanker LS. Passage of drugs across body membranes. Pharmacol Rev. 1962; 14: 501-530. Web site. http://pharmrev. aspetjournals.org/content/14/4/501.short. Accessed August 24, 2016.

Kaufman J, Semo N, Koski W. Microelectrode titration measurements of the pKas and partition and drug distribution coefficients of narcotics and narcotic antagonists and their pH and temperature dependence. J Med Chem. 1975; 18: 647-655.

Ripamonti C, Bruera E. Rectal, buccal and sublingual narcot-ics for the management of cancer pain. J Palliat Care. 1991; 7: 30- 35. Web site. http://psycnet.apa.org/psycinfo/1991-28369-001. Accessed August 24, 2016.

Lawrence AJ, Joshi GP, Michalkiewicz A, Blunnie WP, Mo-riarty DC. Evidence for analgesia mediated by peripheral opioid receptors in inflamed synovial tissue. Eur J Clin Pharmacol. 1992; 43: 351-355. doi: 10.1007/BF02220608

Levine JD, Taiwo YO. Involvement of the mu-opiate recep-tor in peripheral analgesia. Neuroscience. 1989; 32: 571-575.

Sarvizadeh M, Hemati S, Meidani M, et al. Morphine mouthwash for the management of oral mucositis in patients with head and neck cancer. Adv Biomed Res. 2015; 4: 44-46. doi: 10.4103/2277-9175.151254

Vayne-Bossert P, Escher M, de Vautibault CG, et al. Effect Palliat Med Hosp Care Open J of topical morphine (mouthwash) on oral pain due to chemo-therapy-and/or radiotherapy-induced mucositis: A randomized double-blinded study. J Palliat Med. 2010; 13: 125-128. doi: 10.1089/jpm.2009.0195

Cerchietti LC, Navigante AH, Bonomi MR, et al. Effect of topical morphine for mucositis-associated pain following con-comitant chemoradiotherapy for head and neck carcinoma. Can-cer. 2002; 95: 1-10. doi: 10.1002/cncr.10938

Saroja G, Devi PS. Oral morphine solution as an oral rinse or mouth gargle for mucositis pain. Indian J Palliat Care. 2010; 6: 54-55. doi: 10.4103/0973-1075.63138

Nielsen BN, Aagaard G, Henneberg SW, Schmiegelow K, Hansen SH, Romsing J. Topical morphine for oral mucositis in children: Dose finding and absorption. J Pain Sym Manage. 2012; 44: 117-123. doi: 10.1016/j.jpainsymman.2011.06.029

Leandro CA, Alfredo HCN, Korte MW, et al. Potential utility of the peripheral analgesic properties of morphine in stomatitis-related pain: A pilot study. Pain. 2003; 105: 265-273.

Downloads

Published

2016-10-19

How to Cite

Kalpajit Dutta, & Rakesh Garg. (2016). Morphine Mouthwash in Oral Mucositis: A Mini Review. Palliative Medicine and Hospice Care, 2(2), 26–29. https://doi.org/10.17140/PMHCOJ-2-115

Issue

Vol. 2 No. 2 (2016): Volume 2 Issue 2 2016

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All content published in Palliative Medicine and Hospice Care (PMHC) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.